UKNoticeOfficial ✓July 28, 2026· GOV.UK
Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine
What happened
The Court of Appeal has confirmed that firms broke the law by charging excessive and unfair prices for hydrocortisone tablets. This illicit pricing practice spanned "over a decade." The ruling upholds "CMA findings" regarding this misconduct.
Why it matters
This ruling ensures accountability for firms that exploited pricing for "lifesaving NHS-funded medicine." It addresses the financial burden placed on the NHS and potentially impacts future drug pricing regulations.
Who it affects
- ›Firms charged with excessive pricing
- ›Patients needing hydrocortisone tablets
- ›UK justice system
Receipts
The receipts are official. The summary is ours.
Read on GOV.UK ↗Summaries are generated from the official text and may simplify or omit nuance. The official document is the source of truth.
More from UK
UKNoticeOfficial ✓
Drought declared in half of EnglandGOV.UK·Jul 29, 2026
UKNoticeOfficial ✓
PM sets out new path to fix social care together: 29 July 2026GOV.UK·Jul 29, 2026
UKNoticeOfficial ✓
The trajectory in the West Bank and East Jerusalem remains alarming: UK statement at the UN Security CouncilGOV.UK·Jul 28, 2026